. To elucidate the mechanism of action of prokinetic compounds like domperidone, the gastroduodenal preparation of the guinea pig has been studied (2) . In this preparation, domperidone was shown to enhance antro duodenal coordination via specific dopamine receptors located on intramural nerves (4). Other prokinetic dopamine  antagonists  like  metoclopramide  and clebopride  have, in  addition  to their  dopamine  antagonistic  properties, direct stimulatory effects on the  gastrointestinal  cholinergic innervation most  likely by enhancing  the release of acetyl   choline  (5, 6 ). Recently, the spasmolytic trimebutine, a compound not interfering with either the cholinergic or dopaminergic system, was tested in dyspeptic patients (7).
The aim of the present study was to compare the motility effects of domperidone, metoclopramide, clebopride and trimebutine on the gastroduodenal preparation of the guinea pig.
Materials and Methods
Pirbright guinea pigs (350-450 g, fasted overnight) of either sex were killed by cervical dislocation.
The stomach and the first 10 cm of the duodenum with adhering vasculature were removed for experimen tation.
The intraluminal contents were removed by repeated washing.
After ligation of the esophagus, the stomach was filled with 20 ml saline and suspended in 200 ml of oxygenated (95% 02, 5% C02) Krebs-Henseleit solution (KCI, 4.7; CaC12.2H20, 2.5; MgSO4.7H2O, 1.2; NaHC03, 25.0; KH2PO4, 1.2, NaCI, 118.1 ; glucose, 5.55 mM), maintained at 37°C. The duodenum was cannulated and connected with an ultrasonic transit time transducer (Janssen Scientific Instruments Division) to record changes in intraluminal volume and with a bottle of saline to ensure a constant hydrostatic pressure of 6 cm H20 (2, 8) .
Gastric relaxation, as quantified by incremental changes in gastric volume, was induced pharmacologically by intra-arterial injection of dopamine (Janssen Chimica) (2.6x10-7 moles) via the left gastric artery in volumes of 50 /el at intervals of 10 min. When reproducible relaxations were obtained, a compound was administered to the bathing solution. Drug effects were followed for 70 min. To correct for the gradual increase in agonist-induced relaxation with time in the control experiments, the control responses (expressed as % of their initial relaxation at to) were taken as 100% at each time point: to, too, t20, . t70. Agonist-induced relaxations in the presence of a compound (in % of initial value) were then individually calculated as % of the value at the corresponding time point in the control experiments. Dose response curves were made by plotting the percentage inhibition of agonist-induced relaxation against the concentration of a compound.
Spontaneous phasic activity was always present on the stomach and recorded as rhythmic changes in gastric volume. Gastric peristaltic waves either stopped at the pylorus or were propagated to the duodenum (4). The passage of the antral wave to the duodenum was marked on the recording paper. Antro duodenal coordination was quantified as the relative number of antral waves that were propagated to the duodenum, i.e., that were followed by a duodenal contraction in the second quarter of the rhythmic pen deflection. Autonomous duodenal contractions (not linked to the antral wave) were observed only exceptionally and therefore not taken into account. After a 30-min stabilization period, domperidone (Janssen), clebopride (Almirall) metoclopramide (Delagrange) or trimebutine (Jouveinal) were added to the bath solution at varying concentrations. Drug effects were followed for 30 min. The effects of trimebutine were also assessed in the presence of domperidone (6x10-6 M) or naloxone (Endo) (4.5X10-7 M). Three parameters were determined: 1) antral contractile amplitude, expressed as ml of expelled volume; 2) antral frequency, measured as number of contractions per minute; and 3) % antroduodenal coordination. Results were statistically evaluated with Student's two tailed t-test for paired or unpaired obser vations (P<0.05).
Results
Intra-arterial injection of dopamine induced reproducible relaxations of the gastro duodenal preparation (Fig.  1 ). These relaxations could be inhibited upon adminis tration of domperidone in the bathing solution. The maximal effect of domperidone was reached after 50 min (Fig. 1) . Interestingly, as demonstrated in Fig. 1 , domperidone also regularized the spontaneous motor activity and enhanced its amplitude already within 10 min after its administration. Clebopride ( Fig. 1 ) and metoclopramide also effectively antagonized the dopamine-induced relaxa tions. In contrast with domperidone, their effects peaked at 10 min.
The direct effects of the test compounds on spontaneous contractile activity and tone are better demonstrated at higher paper speed (Fig. 2) . Domperidone enhanced the amplitude of the antral contractions and induced duodenal contractions to occur at the same frequency as the antral waves, i.e., domperidone induced a coordinated pattern of antroduodenal motility (Fig. 2) . Similar findings were obtained with metoclopramide but only in some (4/6 at 1.2X10-6 M) experiments with clebopride. In contrast to the latter drugs, trimebutine (Fig. 2) reduced both the tone of the preparation and the amplitude of the spontaneous gastric con tractions.
In preparations with duodenal activity, trimebutine 'nhibited the occurrence of these contractions.
The gastric relaxation induced by trimebutine persisted throughout the experiment (Fig. 2) . It could not be prevented by domperidone (6 x 10-6 M) nor reversed by naloxone (4.5X10-7 M). This effect was dose-dependent ( Fig. 3) with an EC50-value of 3.6 x 10-6 M [lower limit (LL)=2.4X10-6 M; upper limit (UL)=5.5x 10-6 M]. Due to these intrinsic relaxatory effects of trimebutine, its effect on dopamine induced relaxation could not be tested. Dose-response studies revealed that domperidone was most effective in an tagonizing gastric relaxations induced by dopamine (Fig. 4) . Its IC50-value was 1.0x10-6 M (LL=0.6x10-6 M, UL=1.6X10-6 M). In this regard, domperidone was 10 and 17 times more potent than clebopride and metoclopramide, respectively. The IC50 value for clebopride was 1.0X10-5 M (LL=5.7X10-6 M, UL=1.7xlO-5 M)1 for metoclopramide 1.7 x 10-5 M (LL=1.OX 10-5 M, UL=3.0X10 M-5). Both domperidone and metoclopramide significantly enhanced gastric contractile amplitude (Fig. 5 ), but their effects were only observed at a single concentration. The effective concentration of domperidone ap peared 34 times lower than that needed for metoclopramide.
Clebopride did not enhance the amplitude significantly. Trimebutine reduced contractile amplitude (Figs. 1 and 5) . At the optimal concentrations tested, only domperidone and metoclopramide had sig nificant effects, i.e., reduced the frequency of the gastric contractions (Fig. 6 ). Both domperidone (Fig. 2) and me toclopramide enhanced antroduodenal co ordination in a dose-dependent manner (Fig.  7) . The EC50-value for domperidone was 2.8 x 10-7 M (LL=1.6 x 10-7 M, U L=4.7 X 10-7 M). In this regard, domperidone was 160 times more potent than metoclopramide, its EC50-value being 2.2x10-5 M (LL=1.7 x 10-5 M, U L=2.7 x 10-5 M). Clebopride moderately enhanced antroduodenal coordination (Fig.  7) , but only at 1.2 x 10-6 M. From this concentration upwards, the compound induced in some experiments (3/7 at 4.9x10-6 M; 5/6 at 2.0x10-5 M) a short lasting gastric relaxation and inhibition of contractile amplitude. Trimebutine sig nificantly reduced antroduodenal co ordination (Fig. 7) . The EC50-value for this effect of trimebutine was 5.5x10-6 M (LL=3.1 X10-6 M, UL=9.7X10-6 M). Domperidone antagonized the relaxatory effects of dopamine at low concentrations (2, 8) . In this respect, domperidone was more potent than either clebopride or meto clopramide.
The potency order of these compounds is similar to that found for their respective binding affinity to striatal dopamine receptors in vitro (3, 9) as well as for their ED50-values as antagonist against apomor phine-induced vomiting (dopamine receptor mediated) in conscious dogs (10). The observation that domperidone reached its optimal effect after a longer incubation period than metoclopramide is in agreement with experimental data indicating a rapid but short-lasting action of the latter drug (1 1 ). Clebopride is more effective than meto clopramide against dopamine-induced gastric relaxations, whereas metoclopramide is more effective on antroduodenal coordination. This paradox between two chemically closely related compounds remains to be solved. The relatively small effect of clebopride on antro duodenal coordination cannot be explained by its serotonergic blocking properties (6) since cisapride, a chemically-related com pound (without dopamine-antagonistic pro perties) but also effective in antagonizing contractile responses to serotonin (15), does enhance antroduodenal coordination in this preparation in a dose-dependent manner (9, 16).
The findings with these four compounds may help to explain their effects in dyspepsia. Trimebutine is indicated in painful dyspepsia of spastic origin (17) in which the question remains whether either the upper gastro intestinal tract or the colon is causing the discomfort (18). In a double blind cross-over study, domperidone proved superior over trimebutine in functional dyspepsia (7). Domperidone and also metoclopramide have quite opposite effects to trimebutine in that they stimulate antroduodenal motility while moderately reducing gastric contractile fre quency. A similar reduction of gastric frequency by domperidone was also observed in conscious dogs (11 ). Cooke and Stemper (19) showed that gastric emptying rate was optimal at a frequency of about 4 con tractions per min in the dog. Therefore, a moderate reduction in contractile frequency may be important in man as well, in cases where gastric dysrhythmia (20) is the underlying cause of the dyspeptic complaint.
